Jean-Philippe Couderc is an entrepreneur and scientist with experience in the development of groundbreaking technologies with multiple examples of successful commercializations in the field of cardiac safety. Internationally recognized authority in the development of computerized technologies related to cardiology. Scientific founder and Chief Technology Officer of iCardiac Technologies Inc, a company which was purchased in December 2017 by ERT. Founder and Director of the Telemetric and Holter ECG warehouse, an initiative developed with the US FDA under a private public partnership and funded by the National Institute of Health. Holding a position of Special Government Employee at the US-FDA until 2015. Characterized by a creative mind leading to translational scientific discoveries which have been highlighted by major media including the Wall Street Journal.

Gill Tsouri received his BSc, MSc and PhD degrees in Electrical and Computer Engineering from Ben-Gurion University (Israel) in 2000, 2004 and 2008 respectively. His research encompassed Wireless Communications and Signal Processing. Major contributions from his graduate research have been adopted by industrial partners. From 1998 to 2002 he was with Yitran Communications, where he developed cutting edge power-line communication technologies that later became the industry standard. His past entrepreneurship experience includes developing a novel drip irrigation technology and licensing it to Rivulis Irrigation (a leading global company in the field). In September 2008, He joined the Rochester Institute of Technology, where he established the Communications Laboratory in the Kate Gleason College of Engineering. He is now an Associate Professor of Electrical Engineering with research interests in wireless body area networks, biomedical signal processing and wireless physical layer security. He leads basic and applied research projects funded by NIH, Google, Welch-Allyn, General Motors, Xerox, nBn Technologies and Rochester General Hospital.

Thuan Pham is a passionate solutions architect with 15+ years of experience, seeking to deliver a scalable and flexible solution for VPG medical. At iCardiac Technologies, delivered many flexible, scalable solutions in the health IT, and the company had been acquired twice with multiples in returns. Built a highly skilled onshore and offshore Software developers and Testers team at a fraction of cost. Skilled in Lean Startup, Continuous Improvement, Agile, and Business Process Improvement.

Alex Zapesochny co-founded iCardiac Technologies in 2006, which successfully commercialized technologies from the University of Rochester and from Pfizer for better determining whether new pharmaceutical products are safe for the heart.  The company went on to serve the majority of the largest global pharma companies and its research led to significant regulatory changes for streamlining cardiac safety testing in drug development. iCardiac was acquired by the private equity firm Norwest Venture Partners in 2014 and then, under Alex serving as CEO, was acquired in late 2017 by ERT (owned by Nordic Capital).  Previously, he was part of the executive management team of Lenel Systems, a fast-growing developer of enterprise software, hardware and services for the electronic security industry that was acquired by United Technologies. Alex currently serves as Chairman of the Board to Clerio Vision, a vision correction company based on University of Rochester research. His other roles have included being a trial attorney during his tenure as a New York City prosecutor, a policy division staff member in the Washington headquarters of a presidential campaign, and co-founder of an award-winning healthcare non-profit. Alex participates in various community activities, including as a member of the Entrepreneurship & Development Working Group of the Finger Lakes Regional Economic Development Council, as a Trustee of the Center for Governmental Research and as a Board member for a Rochester-based charter school.  Alex received his undergraduate degree from Cornell University and graduate degrees from American University and the University of Oxford.

Dr. Hall is an expert in complete management of pacemakers, defibrillators, and resynchronization devices. He specializes in treatment of patients with atrial fibrillation, especially ablation for atrial fibrillation. He is board certified in Internal Medicine, Cardiovascular Disease and Clinical Cardiac Electrophysiology. Dr. Hall graduated from Emory University in 1992, received his MD from the University of Rochester School of Medicine and Dentistry in 1997. He completed his internal medicine residency at the University of Virginia, and completed his cardiology fellowship and electrophysiology fellowships at the University of Michigan. He then joined the faculty team at the University of Rochester Medical Center in 2004.